Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Thang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ
WARNING LETTER
•Thang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ•June 25, 2025

Thang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ – FDA Warning Letter, Jun 25, 2025

Record Details

Thang Botanicals, Inc., operating as 7ΩHMZ, received a warning letter from the FDA dated June 25, 2025, following inspections of their facilities. The letter addresses significant regulatory violations concerning their dietary supplement products, specifically the 7OHMZ Tropic Thunder Kratom Shot, 7OHMZ 14 mg 7-Hydroxymitragynine Tablets, and 7OHMZ 7-Hydroxymitragynine Gummies. The primary issue is the inclusion of 7-hydroxymitragynine (7-OH) in these products, which the FDA has not evaluated for safety.

The FDA has identified several concerns: 7-OH products have not been approved for safe use, adverse events have been reported, and 7-OH exhibits opioid-like effects. The FDA classifies 7-OH as an unsafe food additive under the Federal Food, Drug, and Cosmetic Act because it lacks premarket approval and is not generally recognized as safe (GRAS). Consequently, products containing 7-OH are deemed adulterated, making their introduction into interstate commerce illegal.

The FDA requires Thang Botanicals to cease the distribution of these products and address the safety concerns associated with 7-OH. The company must ensure compliance with the Act by removing unapproved additives and providing evidence of safety for any new dietary ingredients. Failure to comply could result in further regulatory action, including product seizures or injunctions. The FDA emphasizes the potential appeal of these products to children and the associated risks, urging the company to take immediate corrective measures.

Company
Thang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ
Inspection date
June 25, 2025
Product type
Dietary Supplements
Office
Human Foods Program
Person
  • Ann M. Oxenham (Director)
View Company Profile

ID · 074b1aa4-ad04-43d4-bb7d-92547f74f7c6

Violation Codes10
21 U.S.C. 331(a)21 U.S.C. 321(s)21 U.S.C. 348(a)21 U.S.C. 342(a)(2)(C)(i)21 CFR 18121 CFR 170.3021 CFR 170.30(a)21 CFR 170.30(b)21 CFR 170.30(c)21 U.S.C. 321(ff)(1)(F)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Thang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.